Research map: Understanding regional differences in MASLD: the Indian perspective

Back to the article

Papers in this map

  1. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review · Zobair M. Younossi · 2023 · 3310 citations · Cited by this paper
  2. AQP7 deficiency drives adipose tissue remodeling and disrupts homeostasis · 2025 · Related
  3. New trends on obesity and NAFLD in Asia · Jian-Gao Fan · 2017 · 1143 citations · Cited by this paper
  4. 1,1-Diethoxyethane increases insulin sensitivity and ameliorates obesity and dyslipidemia in mice fed high-fat diet · 2026 · Related
  5. Epidemiology of metabolic dysfunction-associated steatotic liver disease · Zobair M. Younossi · 2024 · 876 citations · Cited by this paper
  6. Risk stratification at prediabetes onset and association with diabetes outcomes using EHR data · 2025 · Related
  7. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review · Wah‐Kheong Chan · 2023 · 761 citations · Cited by this paper
  8. GLP-1 receptor agonism results in reduction in hepatic ethanol metabolism · 2025 · Related
  9. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes · Zobair M. Younossi · 2024 · 393 citations · Cited by this paper
  10. Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) · 2026 · Related
  11. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries · Ehsan Amini‐Salehi · 2024 · 167 citations · Cited by this paper
  12. Adolescence as a key developmental window for nutrition promotion and cardiometabolic disease prevention · 2025 · Related
  13. Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis · S. Shalimar · 2021 · 161 citations · Cited by this paper
  14. Dual SGLT1/2 inhibition with sotagliflozin improves cardiac function and metabolism in type 2 diabetic mice · 2026 · Related
  15. Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges · Mohammad Shafi Kuchay · 2021 · 101 citations · Cited by this paper
  16. An IL6 variant -174 G-C alters cardiac hypertrophy but not cardiometabolic responses to HFD in mice · 2026 · Related
  17. Risk Factors Associated With Non-Alcoholic Fatty Liver Disease in Indians: A Case–Control Study · Shivaram Prasad Singh · 2015 · 85 citations · Cited by this paper
  18. Comparison of polygenic risk scores for type 2 diabetes developed from different ancestry groups · 2025 · Related
  19. Nonalcoholic Fatty Liver Disease: Indian Perspective · Arka De · 2021 · 59 citations · Cited by this paper
  20. CD36: bridging metabolism, inflammation, and reproduction · 2026 · Related
  21. Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities · Govardhan Bale · 2017 · 33 citations · Cited by this paper
  22. Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study) · Viswanathan Mohan · 2025 · 27 citations · Cited by this paper
  23. The socioeconomic and environmental determinants of metabolic dysfunction-associated steatotic liver disease: understanding inequalities in prevalence and outcomes · Dominika Lorek · 2025 · 17 citations · Cited by this paper
  24. The burden of NAFLD (now referred to as MASLD)-related chronic liver disease and cirrhosis from 1990 to 2021 with projections to 2036: a comparative study of global China the United States and India · Juanjuan Zeng · 2025 · 14 citations · Cited by this paper
  25. Prevalence of Non-Alcoholic Fatty Liver Disease in Urban Adult Population in a Tertiary Care Center, Chennai · Mary Chandrika Anton · 2023 · 12 citations · Cited by this paper
  26. Underrepresentation of Asians in diagnostic test development and drug trials in MASLD · Lung‐Yi Mak · 2025 · 7 citations · Cited by this paper
  27. Evaluation of risk factors for non-alcoholic fatty liver disease in India: A systematic review and meta-analysis · Suthanthira Kannan · 2023 · 5 citations · Cited by this paper
  28. MASLD progression in India: A growing concern in the world's diabetes capital · Devaraj Ezhilarasan · 2025 · 2 citations · Cited by this paper
  29. Hepatic steatosis: associated rs2954029 and rs2605100 genetic factors in an Indian population · Dixa Sharma · 2025 · 1 citation · Cited by this paper
  30. Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLD · Meghana Arvind · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)